Jun 14, 2026, 10:00 AM
Relevance: 75
Relevance Confidence: 80
Evidence Strength: 70
Narrative Certainty: 60
Polarization: 10
London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’
London startup Poolbeg Pharma is trialling a drug to prevent cytokine release syndrome in cancer immunotherapy patients. If successful, the oral drug could reduce treatment costs and allow care in community hospitals.